CERO THERAPEUTICS HOLDINGS, INC. (CERO) Form 8-K — May 29, 2026
$CEROForm 8-KItems 1.01, 2.03, 3.02, 9.01Filed May 29, 2026, 4:05 PM ET0001213900-26-062802Original filing
Cero Therapeutics Holdings, Inc. issued a convertible promissory note to SRX Health Solutions, Inc. for a purchase price of $750,000, carrying a principal face value of $937,500 and bearing 10% annual interest. The note matures on May 28, 2027, and allows the lender to convert debt into common stock at a price equal to the lesser of $0.05 or 80% of the average of the five lowest intraday trading prices during the 20 days prior to conversion.
Key figures
- Debt Amount
- 750000
- Interest Rate
- 10
- Maturity Date
- 2027-05-28
- Conversion discount
- 80% of 5 lowest intraday prices over 20 days
- Principal face value
- 937500
- Conversion price floor
- 0.05
- Beneficial ownership limit
- 4.99%
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.